uz
Feedback
PathCast

PathCast

Kanalga Telegram’da o‘tish

Broadcasting & archiving the pathology knowledge base

Ko'proq ko'rsatish
1 890
Obunachilar
+124 soatlar
+37 kunlar
+2030 kunlar
Obunachilarni jalb qilish
Avgust '26
Avgust '26
+21
0 kanalda
Iyul '26
+27
0 kanalda
Get PRO
Iyun '26
+27
0 kanalda
Get PRO
May '26
+31
0 kanalda
Get PRO
Aprel '26
+23
0 kanalda
Get PRO
Mart '26
+16
0 kanalda
Get PRO
Fevral '26
+24
0 kanalda
Get PRO
Yanvar '26
+17
0 kanalda
Get PRO
Dekabr '25
+317
0 kanalda
Get PRO
Noyabr '250
0 kanalda
Get PRO
Oktabr '250
0 kanalda
Get PRO
Sentabr '250
0 kanalda
Get PRO
Avgust '250
0 kanalda
Get PRO
Iyul '250
0 kanalda
Get PRO
Iyun '250
0 kanalda
Get PRO
May '250
0 kanalda
Get PRO
Aprel '250
0 kanalda
Get PRO
Mart '250
0 kanalda
Get PRO
Fevral '250
0 kanalda
Get PRO
Yanvar '250
0 kanalda
Get PRO
Dekabr '24
+61
0 kanalda
Get PRO
Noyabr '24
+109
0 kanalda
Get PRO
Oktabr '24
+180
0 kanalda
Get PRO
Sentabr '24
+54
0 kanalda
Get PRO
Avgust '24
+50
0 kanalda
Get PRO
Iyul '24
+20
0 kanalda
Get PRO
Iyun '24
+12
0 kanalda
Get PRO
May '24
+20
0 kanalda
Get PRO
Aprel '24
+11
0 kanalda
Get PRO
Mart '24
+12
0 kanalda
Get PRO
Fevral '24
+22
0 kanalda
Get PRO
Yanvar '24
+34
0 kanalda
Get PRO
Dekabr '23
+22
0 kanalda
Get PRO
Noyabr '23
+18
0 kanalda
Get PRO
Oktabr '23
+14
0 kanalda
Get PRO
Sentabr '23
+17
0 kanalda
Get PRO
Avgust '23
+23
0 kanalda
Get PRO
Iyul '23
+21
0 kanalda
Get PRO
Iyun '23
+8
0 kanalda
Get PRO
May '23
+6
0 kanalda
Get PRO
Aprel '23
+10
0 kanalda
Get PRO
Mart '23
+8
0 kanalda
Get PRO
Fevral '23
+11
0 kanalda
Get PRO
Yanvar '23
+7
0 kanalda
Get PRO
Dekabr '22
+14
0 kanalda
Get PRO
Noyabr '22
+23
0 kanalda
Get PRO
Oktabr '22
+16
0 kanalda
Get PRO
Sentabr '22
+10
0 kanalda
Get PRO
Avgust '22
+33
0 kanalda
Get PRO
Iyul '22
+6
0 kanalda
Get PRO
Iyun '22
+10
0 kanalda
Get PRO
May '22
+11
0 kanalda
Get PRO
Aprel '22
+19
0 kanalda
Get PRO
Mart '22
+18
0 kanalda
Get PRO
Fevral '22
+31
0 kanalda
Get PRO
Yanvar '22
+248
0 kanalda
Get PRO
Dekabr '21
+2
0 kanalda
Get PRO
Noyabr '21
+10
0 kanalda
Get PRO
Oktabr '21
+10
0 kanalda
Get PRO
Sentabr '21
+5
0 kanalda
Get PRO
Avgust '21
+13
0 kanalda
Get PRO
Iyul '21
+12
0 kanalda
Get PRO
Iyun '21
+409
0 kanalda
Sana
Obunachilarni jalb qilish
Esdaliklar
Kanallar
26 Avgust0
25 Avgust+2
24 Avgust+1
23 Avgust+1
22 Avgust0
21 Avgust+1
20 Avgust0
19 Avgust+1
18 Avgust+2
17 Avgust+1
16 Avgust0
15 Avgust0
14 Avgust+2
13 Avgust+1
12 Avgust0
11 Avgust0
10 Avgust0
09 Avgust0
08 Avgust+2
07 Avgust+1
06 Avgust+1
05 Avgust+1
04 Avgust+2
03 Avgust0
02 Avgust+1
01 Avgust+1
Kanal postlari
Gestational Trophoblastic Diseases ISGyP LiVE Journal Club August 19, 2026 @PathCast

2
Beyond HER2-Negative Practical Interpretation, Scoring, and Reporting of Lower HER2 Expression in Metastatic Breast Cancer. M
Beyond HER2-Negative Practical Interpretation, Scoring, and Reporting of Lower HER2 Expression in Metastatic Breast Cancer. Michelle Shiller, DO, AP, CP, MGP, FACP discusses the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice. @PathCast
393
3
Uterine mesenchymal lesions ISGyP LiVE Journal Club Jun 17, 2026 @PathCast
Uterine mesenchymal lesions ISGyP LiVE Journal Club Jun 17, 2026 @PathCast
316
4
Liver Tumor Classification in the 6th Edition of the WHO Dr. Michael S. Torbenson, MD, Professor of Pathology Mayo Clinic, Ro
Liver Tumor Classification in the 6th Edition of the WHO Dr. Michael S. Torbenson, MD, Professor of Pathology Mayo Clinic, Rochester, USA, discusses @PathCast
633
5
ISGyP LiVE Journal Club Jun 17, 2026 @PathCast
ISGyP LiVE Journal Club Jun 17, 2026 @PathCast
508
6
The morphology-molecular gap in endometrial carcinoma: ambiguous histologies and challenging cases Divya Midha (India) ISGyP
The morphology-molecular gap in endometrial carcinoma: ambiguous histologies and challenging cases Divya Midha (India) ISGyP LiVE Slide Session May 14, 2026 @PathCast
499
7
High-Yield Molecular Pathology for Boards: Part 2 (Hematolymphoid Tumors) Dr. Jeremiah X. Karrs, DO Assistant Professor of Pa
High-Yield Molecular Pathology for Boards: Part 2 (Hematolymphoid Tumors) Dr. Jeremiah X. Karrs, DO Assistant Professor of Pathology and Laboratory Medicine Dartmouth Hitchcock Medical Center & Geisel School of Medicine at Dartmouth @PathCast
499
8
Common and not so common challenges: Intratumoral heterogeneity, mixed histology and subclonality in endometrial carcinoma -
Common and not so common challenges: Intratumoral heterogeneity, mixed histology and subclonality in endometrial carcinoma - Guidance for the practicing pathologist Jutta Huvila (Finland) ISGyP LiVE Webinar May 7, 2026 @PathCast
1
9
Common and not so common challenges: Intratumoral heterogeneity, mixed histology and subclonality in endometrial carcinoma -
Common and not so common challenges: Intratumoral heterogeneity, mixed histology and subclonality in endometrial carcinoma - Guidance for the practicing pathologist Jutta Huvila (Finland) ISGyP LiVE Webinar May 7, 2026 @PathCast
618
10
Evening Specialty Conference - Endocrine Pathology USCAP 115TH Annual Meeting MAKING CONNECTIONS @PathCast
Evening Specialty Conference - Endocrine Pathology USCAP 115TH Annual Meeting MAKING CONNECTIONS @PathCast
742
11
This concludes the USCAP Gynecologic Pathology: Practical Strategies for Modern Practice Series. Tap here for the first video of the series on Telegram or get it on Odysee here.
777
12
USCAP Gynecologic Pathology: Practical Strategies for Modern Practice Series Panel Discussion - Day 3 @PathCast
USCAP Gynecologic Pathology: Practical Strategies for Modern Practice Series Panel Discussion - Day 3 @PathCast
635
13
USCAP Gynecologic Pathology: Practical Strategies for Modern Practice Series Panel Discussion - Day 2 @PathCast
USCAP Gynecologic Pathology: Practical Strategies for Modern Practice Series Panel Discussion - Day 2 @PathCast
521
14
USCAP Gynecologic Pathology: Practical Strategies for Modern Practice Series Panel Discussion - Day 1 @PathCast
USCAP Gynecologic Pathology: Practical Strategies for Modern Practice Series Panel Discussion - Day 1 @PathCast
486
15
High-yield molecular pathology for boards - Part 1 (Solid tumors) Dr. Laura J. Tafe, MD Professor of Pathology and Laboratory
High-yield molecular pathology for boards - Part 1 (Solid tumors) Dr. Laura J. Tafe, MD Professor of Pathology and Laboratory Medicine Dartmouth Hitchcock Medical Center & Geisel School of Medicine at Dartmouth @PathCast
502
16
USCAP Platform and Poster Winners ISGyP LiVE Journal Club April 15, 2026 Moderators: Zehra Ordulu (USA) & Lulu Sun (USA) @Pat
USCAP Platform and Poster Winners ISGyP LiVE Journal Club April 15, 2026 Moderators: Zehra Ordulu (USA) & Lulu Sun (USA) @PathCast
553
17
USCAP Platform and Poster Winners ISGyP LiVE Journal Club April 15, 2026 Moderators: Zehra Ordulu (USA) & Lulu Sun (USA) @PathCast
1
18
HIGH-YIELD GU PATHOLOGY FOR BOARDS Dr. Andres M. Acosta Associate Professor of Pathology Indiana University School of Medicin
HIGH-YIELD GU PATHOLOGY FOR BOARDS Dr. Andres M. Acosta Associate Professor of Pathology Indiana University School of Medicine, USA @PathCast
657
19
Squamous Cell Carcinoma of the Cervix Rafael Salim (Brazil) ISGyP LiVE Slide Session April 9, 2026 @PathCast
Squamous Cell Carcinoma of the Cervix Rafael Salim (Brazil) ISGyP LiVE Slide Session April 9, 2026 @PathCast
638
20
Foundation of HER2 Gastric Cancer ASCO-CAP Guidelines Overview of the Differences Between ASCO-CAP Breast and Gastric Cancer
Foundation of HER2 Gastric Cancer ASCO-CAP Guidelines Overview of the Differences Between ASCO-CAP Breast and Gastric Cancer Scoring. Hear from Josef Ruschoff, MD, PhD, an expert in HER2 IHC whose work has contributed to current scoring guidelines. @PathCast
594